HEAD AND NECK
Clinical trials for HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK trials appear
Sign up with your email to follow new studies for HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody EPI-326 enters first human trials for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called EPI-326 in about 110 people with advanced lung or head & neck cancers that have specific EGFR mutations. The drug is a bispecific antibody designed to target cancer cells more precisely. The main goals are to check safety, find the r…
Matched conditions: HEAD AND NECK
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Recruiting nowThis early-stage trial tests a fluorescent dye attached to the cancer drug nivolumab. The dye is meant to make cancer cells glow during surgery, helping surgeons remove them more precisely. The study will enroll 40 people with head and neck cancer who are already scheduled for su…
Matched conditions: HEAD AND NECK
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC